Related Experiment Video
Updated: May 15, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches
Sudin Bhattacharya1, Lisl K M Shoda, Qiang Zhang
1Institute for Chemical Safety Sciences, The Hamner Institutes for Health Sciences Research Triangle Park, NC, USA.
Abstract:
We provide an overview of computational systems biology approaches as applied to the study of chemical- and drug-induced toxicity. The concept of "toxicity pathways" is described in the context of the 2007 US National Academies of Science report, "Toxicity testing in the 21st Century: A Vision and A Strategy." Pathway mapping and modeling based on network biology concepts are a key component of the vision laid out in this report for a more biologically based analysis of dose-response behavior and the safety of chemicals and drugs. We focus on toxicity of the liver (hepatotoxicity) - a complex phenotypic response with contributions from a number of different cell types and biological processes. We describe three case studies of complementary multi-scale computational modeling approaches to understand perturbation of toxicity pathways in the human liver as a result of exposure to environmental contaminants and specific drugs. One approach involves development of a spatial, multicellular "virtual tissue" model of the liver lobule that combines molecular circuits in individual hepatocytes with cell-cell interactions and blood-mediated transport of toxicants through hepatic sinusoids, to enable quantitative, mechanistic prediction of hepatic dose-response for activation of the aryl hydrocarbon receptor toxicity pathway. Simultaneously, methods are being developing to extract quantitative maps of intracellular signaling and transcriptional regulatory networks perturbed by environmental contaminants, using a combination of gene expression and genome-wide protein-DNA interaction data. A predictive physiological model (DILIsym™) to understand drug-induced liver injury (DILI), the most common adverse event leading to termination of clinical development programs and regulatory actions on drugs, is also described. The model initially focuses on reactive metabolite-induced DILI in response to administration of acetaminophen, and spans multiple biological scales.
Insights
Computational systems biology offers new ways to study chemical and drug toxicity, focusing on "toxicity pathways." These methods enable better prediction of liver toxicity from environmental contaminants and drugs.
Area of Science:
- Computational systems biology
- Toxicology
- Network biology
Background:
- The 2007 National Academies of Science report, "Toxicity testing in the 21st Century: A Vision and A Strategy," proposed biologically based toxicity analysis.
- Pathway mapping and modeling are crucial for understanding chemical and drug safety and dose-response relationships.
Purpose of the Study:
- To provide an overview of computational systems biology approaches for studying chemical- and drug-induced toxicity.
- To illustrate these approaches through case studies focused on liver toxicity (hepatotoxicity).
Main Methods:
- Development of a spatial, multicellular "virtual tissue" model of the liver lobule for predicting dose-response.
- Extraction of quantitative maps of intracellular signaling and transcriptional regulatory networks.
- Utilizing a predictive physiological model (DILIsym™) for drug-induced liver injury (DILI).
Main Results:
- The virtual tissue model enables quantitative, mechanistic prediction of hepatic dose-response for specific toxicity pathways (e.g., aryl hydrocarbon receptor).
- Methods are being developed to map perturbed intracellular networks using multi-omics data.
- The DILIsym™ model provides insights into drug-induced liver injury, starting with acetaminophen.
Conclusions:
- Computational systems biology offers powerful, multi-scale modeling approaches to understand complex toxicity mechanisms.
- These methods advance the vision for a more biologically informed approach to chemical and drug safety assessment.
- Predictive models like DILIsym™ are essential for evaluating drug safety and mitigating risks in clinical development.
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Toxicokinetics: Overview
Drug Toxicity: Dose-Dependent Reactions
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

